|
A rich diversity of ion channel genes and families are now known from
molecular cloning and genome sequencing efforts. This abundance of
ion channel genes poses dual problems: most have unknown functions
and few have defined pharmacologies that could be used to dissect their
biophysical or physiological mechanisms of action. Indeed, there are
entire channel families that are pharmacological orphans. Unraveling
the functions of this multitude of ion channels demands the development
of new tools for the manipulation of a given ion channel's action in
a in a variety of in vivo and in vitro settings.
To accelerate the pace at which ion channel modulators can be discovered
and characterized, we are developing approaches for identifying small
molecule ion channel blockers as well as a general means to generate
high affinity, specific inhibitors and activators of ion channels through
the use of molecular evolution and selection methods. Uncovering new
modulators would present the necessary tools to unlock a wide range
of questions from basic channel biophysics to physiology.
Our lab has recently demonstrated the feasibility of using complementation
of a potassium transport deficient strain of yeast as a means to identify
ion channel blockers and map their sites of action. Studies of the
potassium channel blocker barium, uncovered barium-resistant inward
rectifier mutants that challenge current notions about how potassium
channels work (Chatelain et al., 2005). These studies also emphasize
the utility of using genetic selection approaches for probing ion channel-blocker
interactions. Further work in the lab is dedicated to expanding genetic
selections to identify a range of small molecule and peptide modifiers
of channel activity. Such molecules should provide important tools
for research and may help accelerate the development of ion channel-directed
drugs. |